The molecular and gene/miRNA expression profiles of radioiodine resistant papillary thyroid cancer

BACKGROUND: Papillary thyroid cancer (PTC) is the most frequent endocrine tumor. Radioiodine (RAI) treatment is highly effective in these tumors, but up to 60% of metastatic cases become RAI-refractory. Scanty data are available on either the molecular pattern of radioiodine refractory papillary thy...

Descripción completa

Detalles Bibliográficos
Autores principales: Colombo, Carla, Minna, Emanuela, Gargiuli, Chiara, Muzza, Marina, Dugo, Matteo, De Cecco, Loris, Pogliaghi, Gabriele, Tosi, Delfina, Bulfamante, Gaetano, Greco, Angela, Fugazzola, Laura, Borrello, Maria Grazia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667839/
https://www.ncbi.nlm.nih.gov/pubmed/33198784
http://dx.doi.org/10.1186/s13046-020-01757-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667839/
https://www.ncbi.nlm.nih.gov/pubmed/33198784
http://dx.doi.org/10.1186/s13046-020-01757-x

Ejemplares similares